The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 24, 2019
Filed:
Jul. 11, 2012
Volker Schellenberger, Palo Alto, CA (US);
Pei-yun Chang, Menlo Park, CA (US);
Fatbardha Varfaj, Mountain View, CA (US);
Sheng Ding, Redwood City, CA (US);
Joshua Silverman, Sunnyvale, CA (US);
Chia-wei Wang, Milpitas, CA (US);
Benjamin Spink, San Carlos, CA (US);
Willem P. Stemmer, Los Gatos, CA (US);
Volker Schellenberger, Palo Alto, CA (US);
Nathan Geething, Santa Clara, CA (US);
John Kulman, Belmont, MA (US);
Tongyao Liu, Lexington, MA (US);
Garabet G. Toby, North Reading, MA (US);
Haiyan Jiang, Belmont, MA (US);
Robert Peters, Needham, MA (US);
Deping Wang, Sharon, MA (US);
Baisong Mei, Waban, MA (US);
Volker Schellenberger, Palo Alto, CA (US);
Pei-Yun Chang, Menlo Park, CA (US);
Fatbardha Varfaj, Mountain View, CA (US);
Sheng Ding, Redwood City, CA (US);
Joshua Silverman, Sunnyvale, CA (US);
Chia-wei Wang, Milpitas, CA (US);
Benjamin Spink, San Carlos, CA (US);
Willem P. Stemmer, Los Gatos, CA (US);
Nathan Geething, Santa Clara, CA (US);
John Kulman, Belmont, MA (US);
Tongyao Liu, Lexington, MA (US);
Garabet G. Toby, North Reading, MA (US);
Haiyan Jiang, Belmont, MA (US);
Robert Peters, Needham, MA (US);
Deping Wang, Sharon, MA (US);
Baisong Mei, Waban, MA (US);
BIOVERATIV THERAPEUTICS INC., Waltham, MA (US);
Abstract
The present invention relates to compositions comprising factor VIII coagulation factors linked to extended recombinant polypeptide (XTEN), isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of making and using such compositions in treatment of factor VIII-related diseases, disorders, and conditions.